Kentucky Revised Statutes Title XVIII. Public Health § 217.5403.Eligibility requirements for treatment with investigational drug, biological product, or device

(1) A terminal illness that is attested to by the patient's treating health care provider;

(2) Considered all other treatment options currently approved by the United States Food and Drug Administration;

(3) Received a recommendation from the patient's treating health care provider for an investigational drug, biological product, or device;

(4) Given written informed consent for the use of the investigational drug, biological product, or device; and

(5) Documentation from the treating health care provider that the patient meets the requirements of this section.